Gene: FBP1
Official Full Name: fructose-bisphosphatase 1provided by HGNC
Gene Summary: Fructose-1,6-bisphosphatase 1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. Fructose-1,6-diphosphatase deficiency is associated with hypoglycemia and metabolic acidosis. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07464 | FBP1 Knockout cell line (HeLa) | Human | FBP1 | 1:3~1:6 | Negative | Online Inquiry |
FBP1 Gene Knockout Cell Lines are specialized cellular models in which the FBP1 gene, encoding fructose-1,6-bisphosphatase, has been intentionally disrupted to study the implications of its absence on cellular metabolism and function. These cell lines serve as invaluable tools for investigating the role of gluconeogenesis and associated metabolic pathways, providing insights into energy homeostasis and glucose regulation.
The FBP1 gene knockout impairs the conversion of fructose-1,6-bisphosphate to fructose-6-phosphate, effectively hampering gluconeogenesis. This alteration allows researchers to dissect the metabolic adaptations that occur in response to altered FBP1 expression, including shifts in glycolysis and the TCA cycle. By utilizing these cell lines, scientists can effectively mimic pathological states such as diabetes and metabolic syndrome, leading to a better understanding of disease mechanisms.
FBP1 Gene Knockout Cell Lines hold significant importance in both research and clinical applications. In research settings, they provide a platform for screening potential therapeutic agents aimed at metabolic disorders, while in clinical settings, they could facilitate the development of personalized medicine approaches to treat conditions linked to metabolic dysregulation.
One of the distinct advantages of using our FBP1 Gene Knockout Cell Lines over traditional models is their specificity and reliability, ensuring that research outcomes are directly attributable to the absence of the FBP1 function. Furthermore, these cell lines are validated for consistent performance, enabling reproducibility in experiments—a critical factor for successful research initiatives.
The value of these cell lines to researchers and clinicians lies in their ability to contribute significantly to the understanding of metabolic pathways and disease mechanisms, opening avenues for innovative therapeutic interventions. With extensive expertise in genetic engineering and cell line development, our company is dedicated to offering high-quality biological products that empower researchers to pave the way for advanced scientific discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.